Topics

Companies Related to "Cancer Therapeutic Drugs Market Global Forecasts from 2019" [Most Relevant Company Matches] RSS

05:48 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Cancer Therapeutic Drugs Market Global Forecasts from 2019" found in our extensive corporate database of over 50,000 company records.

Showing "Cancer Therapeutic Drugs Market Global Forecasts from 2019" Companies 1–25 of 11,000+

Relevant

Inex Pharmaceuticals Corporation

INEX Pharmaceuticals Corporation is a biopharmaceutical company that utilizes proprietary drug delivery systems and therapeutic compounds to increase the effectiveness and reduce the side-effects of anti-cancer therapies. INEX's strategy has been to develop technology capable of making anti-cancer drugs more effective and reducing their side-effects, thus giving these drugs a competitive advantage...


AVI BioPharma

AVI BioPharma is an emerging biopharmaceutical company and a pioneer in the development of therapeutic products based upon three platform technologies: - therapeutic cancer vaccines, - gene-targeted drugs (antisense), and, - drug delivery technologies.The Company focuses its three platform technologies on two important clinical areas, cancer and cardiovascular disease. The Company ...

Pointilliste

Pointilliste is a biopharmaceutical company focused on discovering and bringing to market new therapeutic drugs to combat human diseases. Pointilliste has developed an exciting new platform technology which it is using to discover new ways of treating cancer and inflammation.In a manner analogous to the painting technique, Pointilliste discovers novel therapeutics using Canvases. These Canvases di...


Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis and forecasting that is essential in today’s ultra-competitive pharmaceutical and biotech markets. Arrowhead analysts draw upon the most up-to-date information and lend their industry expertise t...

GANYMED Pharmaceuticals AG

GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy of current solid cancer therapeutics is severely limited, because their molecular targets are elevated in a subset of a particular cancer but they are also found widely in normal tissues. In contrast...

Compass Intelligence

Compass Intelligence, a global consulting and market analytics firm, specializes in segment and vertical market intelligence for the high-tech and telecom industries; and offers clients a tailored research experience through excellent customer support. Compass Intelligence provides subscriptions and research reports, insight videos, forecasts, competitive analysis, market data and expert recommend...

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...

Acetylon Pharmaceuticals, Inc.

Acetylon Pharmaceuticals, Inc. is applying its unique capabilities to discover and develop next-generation, HDAC isoform-selective small molecule drugs to realize the therapeutic potential of HDAC inhibition to treat cancer, autoimmune and other diseases, while reducing the side effects common to this class of drugs. The Company is based on technolo...

Acetylon Pharmaceuticals Inc.

Acetylon Pharmaceuticals, Inc. is applying its unique capabilities to discover and develop next-generation, highly selective small molecule drugs to realize the therapeutic potential of HDAC inhibition to treat cancer, autoimmune and other diseases, while reducing the side effects common to this class of drugs. The Company is located in Boston and is based...

Marshall Edwards

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of oncology drugs - multiple signal transduction regulators (abbreviated as 'MSTRs') that reach to the heart of the cancer process.The source of this new range of drugs is a family of chemicals, discove...

Biopharmacopae

For centuries plants have been a very important source of medications. Less than 5% of the 300,00 plant species have ever been investigated for their medicinal properties. An estimated one-quarter of the prescription drugs contain active ingredients derived from plants. Widely used drugs from plant extracts include the antibiotic, immunosuppressant, and the anti-anti cancer agents. Global over the...

Cristal Therapeutics

Cristal Therapeutics, established in Maastricht, focuses on the development of nanomedicines with improved therapeutic efficacy. The pipeline comprises of products based on drugs in development and also on the market, in combination with the patented CriPec® platform, for the treatment of various diseases, including cancer and chronic inflammatory disor...

Tosk Incorporated

Neurodegenerative diseases and cancer. The Company’s AON QTS technology not only targets the neurodegeneration process, which will allow discovered drugs to be applicable to a variety of AON diseases caused by different initial events (e.g., Alzheimer’s, Parkinson’s, multiple sclerosis, etc.), but also optimizes the rational drug design approach by selecting for drugs based on their therapeu...

The Institute for Global Futures

The Institute for Global Futures is a San Francisco based think tank that forecasts innovations and trends. IGF provides keynote presentations, futures research services, and strategy consulting to the Fortune 1000, associations and governments.

European Organisation for Research and Treatment of Cancer (EORTC)

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients’ quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individualEuropean l...

Gene Network Sciences

Gene Network Sciences (GNS) is a privately held biosimulation company with offices in Ithaca, New York, and Cambridge, Massachusetts. Founded in 2000, GNS creates data-driven compound simulation models that help pharmaceutical companies improve the quality of their drug candidates. Leading the company's multi-disciplinary approach are scientists specializing in molecular biology, computer science,...

Meditope Biosciences, Inc.

Meditope Biosciences is a biotechnology company developing best-in-class antibody-based cancer products. Discovered at City of Hope, a National Cancer Institute designated Comprehensive Cancer Center, Meditope’s technology is capable of turning any mAb into a proprietary, site-specific “Lego-like” system that is able to attach and detach drugs ...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...

Cytopia Ltd.

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through subsidiaries based in Australia and the USA and specialises in developing new small molecule compounds with an improved therapeutic profile for the treatment of cancer.

EvaluatePharm

EvaluatePharma® – helping you to analyse the past and future performance of the pharmaceutical and biotechnology business sector.EvaluatePharma® provides comprehensive coverage of more than 400 companies and over 11,000 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.Historic sales (since 1986), c...

Proteome Systems Limited

Proteome Systems Limited is an Australian based biotechnology company which discovers and develops diagnostic and therapeutic products. The Company has extensive expertise in the discovery and development of protein biomarkers. Our focus is on areas where there are large global markets and unmet need for diagnostics and drugs such as respiratory disease, neurodegenerative disease, cancer and infec...

Inhale Therapeutic Systems

Inhale Therapeutic Systems, Inc. is creating an inhalation drug delivery system to deliver a wide range of drugs, includingpeptides, proteins and other macromolecule drugs to the deep lung. Inhale is using this system principally to enable non-invasive delivery of macromolecule drugs currently administered by injection.

Evaluate Ltd.

Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis. EvaluatePharma delivers exclusive consensus forecasts and trusted commercial insight into biotech and pharmaceutical performance. EvaluateMedTech sets a new standard in integrated analysis and consensus forecasts of the global medical device and diagnostic indust...

Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.

EiRx Therapeutics Limited

The Company is based around original concepts and discoveries made by Prof. Tom Cotter (CSO). Tom is a leading international expert in this field and is Professor of Biochemistry at University College Cork. The goal of applied research in apoptosis is to develop new drugs that effectively modulate apoptosis in disease states in a safe manner. EiRx Therapeutics believes that there will be significa...


More From BioPortfolio on "Cancer Therapeutic Drugs Market Global Forecasts from 2019"

Quick Search

Corporate Database Quicklinks